AQST

AQST

USD

Aquestive Therapeutics Inc. Common Stock

$6.040-0.370 (-5.772%)

即時價格

Healthcare
Drug Manufacturers - Specialty & Generic
美國

價格圖表

Loading Chart...

關鍵指標

市場指標
公司基本面
交易統計

市場指標

開盤

$6.410

最高

$6.410

最低

$5.790

交易量

3.85M

公司基本面

市值

736.9M

行業

Drug Manufacturers - Specialty & Generic

國家

United States

交易統計

平均交易量

3.10M

交易所

NGM

貨幣

USD

52週範圍

最低 $2.12當前 $6.040最高 $7.55

相關新聞

GlobeNewswire

Aquestive Therapeutics Announces Leadership Expansion to Support Growth

Changes strategically aligned to support planned launch of Anaphylm™ (dibutepinephrine) Sublingual Film, if approved by the FDA, and to accelerate the Company's ongoing development initiatives Matthew Davis, M.D.,

查看更多
Aquestive Therapeutics Announces Leadership Expansion to Support Growth
GlobeNewswire

Aquestive Therapeutics to Participate in a Fireside Chat Hosted by Piper Sandler

WARREN, N.J., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients'

查看更多
Aquestive Therapeutics to Participate in a Fireside Chat Hosted by Piper Sandler
GlobeNewswire

Aquestive Therapeutics to Attend 2025 ACAAI Annual Meeting

WARREN, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients'

查看更多
Aquestive Therapeutics to Attend 2025 ACAAI Annual Meeting
GlobeNewswire

Aquestive Therapeutics to Report Third Quarter 2025 Financial Results and Recent Business Highlights on November 5 and Host Conference Call on November 6 at 8:00 a.m. ET

WARREN, N.J., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients'

查看更多
Aquestive Therapeutics to Report Third Quarter 2025 Financial Results and Recent Business Highlights on November 5 and Host Conference Call on November 6 at 8:00 a.m. ET